Metastatic Castration-Resistant Prostate Cancer Therapeutics Market
The global metastatic castration-resistant prostate cancer (mCRPC) therapeutics market size was valued at USD 16.46 billion in 2024. The market is projected to grow from USD 21.04 billion in 2025 to USD 87.19 billion by 2032, exhibiting a CAGR of 22.5% during the forecast period. North America dominated the metastatic castration-resistant prostate cancer therapeutics market with a market share of 53.77% in 2024.
-
Follow
-
0
-
Embed
-
Share
-
Upload
